Aimee Payne

Dermatology, University of Pennsylvania, United States of America

Any competing interests declared are displayed with individual evaluations.

Faculty Member: Dermatology > Acquired & Inherited Bullous Disorders (since 02 November 2006)

All recent recommendations

• 3.0
  Autoantibodies in the Autoimmune Disease Pemphigus Foliaceus Induce Blistering via p38 Mitogen-Activated Protein Kinase-Dependent Signaling in the Skin.
  Recommended by Aimee Payne
  
• 3.0
  Role of thiopurine methyltransferase activity in the safety and efficacy of azathioprine in the treatment of pemphigus vulgaris.
  Recommended by Aimee Payne
  
• 3.0
  Development of an IgG4-Based Predictor of Endemic Pemphigus Foliaceus (Fogo Selvagem).
  Recommended by Aimee Payne
  
• 4.9
  Loss of desmocollin 3 in mice leads to epidermal blistering.
  Recommended by Marcel Jonkman with Marieke Bolling, Aimee Payne, Takashi Hashimoto
  
• 6.0
  The classification of inherited epidermolysis bullosa (EB): Report of the Third International Consensus Meeting on Diagnosis and Classification of EB.
  Recommended by Aimee Payne
  
• 3.0
  p120-catenin is a novel desmoglein 3 interacting partner: Identification of the p120-catenin association site of desmoglein 3.
  Recommended by Aimee Payne
  
• 3.3
  E-cadherin is an additional immunological target for pemphigus autoantibodies.
  Recommended by Aimee Payne, Yumi Aoyama, Detlef Zillikens with Enno Schmidt
  
• 4.8
  The IgM Anti-Desmoglein 1 Response Distinguishes Brazilian Pemphigus Foliaceus (Fogo Selvagem) from Other Forms of Pemphigus.
  Recommended by Cassian Sitaru, Aimee Payne
  
• 3.0
  Frequency of shifts over time in the profile of antidesmoglein antibodies in pemphigus vulgaris.
  Recommended by Aimee Payne
  
• 6.6
  A single cycle of rituximab for the treatment of severe pemphigus.
  Recommended by Aimee Payne, Marcel Jonkman, Mark Berneburg, Dedee Murrell with Supriya Venugopal
  
• 3.0
  Randomized controlled open-label trial of four treatment regimens for pemphigus vulgaris.
  Recommended by Aimee Payne
  
• 3.0
  Introducing a novel Autoimmune Bullous Skin Disorder Intensity Score (ABSIS) in pemphigus.
  Recommended by Aimee Payne
  
• 8.3
  Humanization of autoantigen.
  Recommended by Aimee Payne, Cassian Sitaru, Takashi Hashimoto, Stefan Martin
  
• 3.0
  Accelerating effects of epidermal growth factor on skin lesions of pemphigus vulgaris: a double-blind, randomized, controlled trial.
  Recommended by Aimee Payne
  
• 3.0
  A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of pemphigus.
  Recommended by Aimee Payne
  
• 3.0
  Inhibition of Rho A activity causes pemphigus skin blistering.
  Recommended by Aimee Payne
  
• 4.8
  p38MAPK inhibition prevents disease in pemphigus vulgaris mice.
  Recommended by Aimee Payne, Detlef Zillikens
  
• 6.5
  Treatment of pemphigus vulgaris with rituximab and intravenous immune globulin.
  Recommended by Conrad Hauser, Aimee Payne, Lindy Fox